Press

International Clinical Trials Day: Driving healthcare innovation through Artificial Intelligence

20/05/2025

Healthcare · Access to innovation · Digitalization

• Spain positions itself as a European leader in clinical trials, while facing challenges such as improving clinical data coding and increasing investment in R&D.
• The TerminAI project aims to optimize healthcare data management through artificial intelligence, enhancing the efficiency and accuracy of clinical information coding.
• This project is being developed by a consortium led by the Basque Health Cluster and composed of NorayBio, BIOLAN, Vicomtech, EProcessMed, AseBio, and the start-up Devol, under the Ministry of Industry and Tourism’s support program for innovative business clusters.

AseBio

Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to market

13/05/2025

Healthcare · Access to innovation · Financing

• Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the need to promote effective mechanisms for support, funding, and collaboration to transform scientific knowledge into real solutions for patients.
• Although Spain has a solid biomedical ecosystem and holds a prominent position in clinical trials, it still faces major challenges in bringing innovations to market.
• Strengthening public-private collaboration, boosting investment, and developing a mature business ecosystem capable of competing globally remain key challenges for Spain.
   

AseBio

BIOSPAIN 2025: The Role of the Biotechnology Industry in the EU’s Strategic Autonomy

25/04/2025

BioSpain

• Europe’s ability to develop biotech solutions is crucial to securing its economic and strategic future.
• Under the motto “Global crossroads, local vibes”, the event aims to connect local talent with European and American ecosystems.
• BIOSPAIN 2025 will feature the Green Innovation Forum, a dedicated space for companies in the agricultural, food, and industrial biotechnology sectors.
   

AseBio

Biotechnology emerges as the great ally in the face of the climate crisis

26/03/2025

Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy · Circular economy

• Biotechnology has consolidated itself as a strategic tool to combat climate change, driving innovation in sectors such as agriculture, energy, and industry.
• Innovative solutions like bioenergy production, chemical recycling of plastics, and the use of microalgae are transforming key sectors.
• Thanks to biotechnology research and development, it is possible to move toward a greener and more resilient economic model.
   

AseBio

Biotechnology advances in the development of key therapies for kidney diseases

13/03/2025

• It is estimated that chronic kidney disease (CKD) affects approximately 850 million people worldwide.
• World Kidney Day highlights that implementing global early detection policies is crucial to reduce healthcare costs associated with kidney failure and improve patients’ quality of life.
• By 2040, CKD is projected to become the fifth leading cause of years of life lost, emphasizing the urgent need for global strategies to combat this disease.
   

AseBio

Women Represent 29.2% of Management Teams in Biotechnology Companies in Spain

08/03/2025

Services · Talento

• For the past seven years, women’s participation in the biotech sector has exceeded 50%, and since 2020, the representation percentage has remained at 53%.
• 60% of personnel engaged in R&D activities within biotechnology companies are women.
• At AseBio, we are celebrating the third edition of the program "A Day with a Biotech Woman," which introduces female students to the inner workings of a biotechnology company and the various career opportunities the sector offers, with a focus on encouraging entrepreneurship.
  
   

AseBio

AseBio welcomes the designation of CNCps as a Notified Body for Certifying In Vitro Diagnostic Medical Devices

20/02/2025

Healthcare · Access to innovation · Innovative drugs

• It joins the other 13 European entities authorized to assess the compliance of these products before they reach the market.
• We trust that this decision will help reduce the bottleneck caused by the high demand for certification under the new regulatory framework and the limited availability of certification capacities, which negatively impacts innovative biotechnology companies developing IVDs.
• We extend our support to the Administration, and particularly to CNCps, to facilitate companies' compliance with the requirements introduced by Regulation (EU) 2017/746 through training initiatives.
   

AseBio

BIOSPAIN 2025 returns to Barcelona with a strong commitment to internationalization: ‘Global Crossroads, Local Vibes’

18/02/2025

BioSpain

• BIOSPAIN 2025, taking place from October 7 to 9, aims to match the record-breaking figures of its last edition: more than 2,200 professionals from 34 countries worldwide, over 5,000 one-to-one meetings, and more than 81 national and international investors.
• During the presentation event, AseBio, Biocat, the Generalitat of Catalonia, and the Barcelona City Council highlighted the significance of hosting this congress in the Catalan capital once again, which will also be held in this venue in 2027 and 2029.
  
   

AseBio

Biotechnology as a Driver of Innovation in the Energy Sector

14/02/2025

Healthcare · Climate change · Bioeconomy · Circular economy

• The integration of renewable energies and the valorization of biomass are revolutionizing the biotechnology sector. Companies like Natac are leading this transformation with intelligent and sustainable biorefinery models that minimize waste and optimize energy efficiency.
• The growing need for autonomous medical devices is driving research in bio-batteries, a sustainable alternative that uses metabolic processes to generate energy. TECNALIA is working on innovative solutions that will reduce the environmental impact of the healthcare sector.
• Technology centers like Leitat are committed to biofuels, green hydrogen, and sustainable energy storage to lead the change in Europe.
  
   

AseBio